id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-289461-bnusv816	Droste, M. C.	Economic Benefits of COVID-19 Screening Tests	2020-10-27		.txt	text/plain	7911	444	54	The analysis is undertaken using a behavioral SIR model for the United States with 5 age groups, 66 economic sectors, screening and diagnostic testing, and partial adherence to instructions to quarantine or to isolate. Using our epidemiological-economic model, we project 66,000 deaths averted, an increase in GDP of $248 billion, and an increase in federal tax revenues of $68 billion over the counterfactual period of the program, June 1 -December 31, 2020, relative to a baseline with diagnostic but not screening testing. Testing costs are somewhat higher, but because the effective adherence rate is higher under this program than in Panel A, deaths averted rise to 153,000 and the increase in GDP is larger, $544 billion, for weekly testing. Relative to this literature, our main contribution is to provide carefully calibrated and estimated model for assessing the net economic, fiscal, and total (including mortality) benefits of multistep imperfect screening testing in conjunction with diagnostic testing.	./cache/cord-289461-bnusv816.txt	./txt/cord-289461-bnusv816.txt